{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'LIST OF TABLES', 'Table 1:', 'Study Procedures and Assessments', '52', 'Table 2:', 'Maximum Daily Dose of IMP by Study Day and Weight Category at', 'Baseline', '72', 'Table 3:', 'Blood Volumes', '75', 'Table 4:', 'Clinical Laboratory Tests', '90', 'Table 5:', 'Allowed Medications', '205', 'Table 6:', 'Prohibited QTc-Prolonging Drugs', '207', 'Table 7:', 'Prohibited Antipsychotic Drugs', '207', 'Table 8:', 'Other Prohibited Drugs', '208', '28']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'LIST OF FIGURES', 'Figure 1: Overall Study Schema', '45', 'Figure 2: Distribution of AUC of Total (a+B)-HTBZ for Selected Doses Based on', 'Weight Categories', '209', '29']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'LIST OF ABBREVIATIONS AND DEFINITIONS OF TERMS', 'Table of Abbreviations', 'Abbreviation or', 'Explanation', 'Specialist Term', '21CFR', 'Title 21 Code of Federal Regulations', 'ADHD', 'Attention Deficit Hyperactivity Disorder', '-HTBZ', 'alpha-dihydrotetrabenazine', 'ADL', 'activities of daily living', 'ALP', 'alkaline phosphatase', 'ALT', 'alanine aminotransferase (SGPT)', 'ANC', 'absolute neutrophil count', 'ANCOVA', 'analysis of covariance', 'AST', 'aspartate aminotransferase (SGOT)', 'AUC', 'area under the curve', '\u00df-HCG', 'beta-human chorionic gonadotropin', '\u00df-HTBZ', 'beta-dihydrotetrabenazine', 'bid', 'twice a day', 'BL', 'baseline visit', 'BP', 'blood pressure', 'BUN', 'blood urea nitrogen', 'CBIT', 'comprehensive behavioral intervention for tics', 'CBT', 'cognitive behavioral therapy', 'CDI-2', \"Children's Depression Inventory, Second Edition\", 'CDMS', 'clinical data management system', 'CNS', 'central nervous system', 'CRF', 'case report form', 'C-SSRS', 'Columbia-Suicide Severity Rating Scale', 'CST', 'Clinical Surveillance and Training', 'CYP', 'cytochrome P450', 'CYP2D6', 'cytochrome P450 2D6', 'DSM-VTM', 'Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition', '30']\n\n###\n\n", "completion": "END"}